E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/14/2013 in the Prospect News PIPE Daily.

Resolute Oncology takes in $58,000 through private placement of shares

Company sells 116,000 common shares at $0.50 per share in offering

By Devika Patel

Knoxville, Tenn., March 14 - Resolute Oncology Inc. completed a $58,000 private placement of stock on March 13, according to an 8-K filed Thursday with the Securities and Exchange Commission.

The company sold 116,000 common shares at $0.50 per share. The price per share is a 50% discount to the March 12 closing share price of $1.00.

Based in Sherman Oaks, Calif., the company develops, launches and markets biopharmaceutical products and technologies to treat cancers.

Issuer:Resolute Oncology Inc.
Issue:Common stock
Amount:$58,000
Shares:116,000
Price:$0.50
Warrants:No
Settlement date:March 13
Stock symbol:OTCBB: REON
Stock price:$1.00 at close March 12
Market capitalization:$37.4 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.